SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001213900-20-016413
Filing Date
2020-07-01
Accepted
2020-07-01 07:00:32
Documents
1
Group Members
KFIR SILBERMAN

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 3 TO SCHEDULE 13D ea123710-13da3pure_therap.htm SC 13D/A 70177
  Complete submission text file 0001213900-20-016413.txt   71682
Mailing Address 4 ARIEL SHARON STREET HASHAHAR TOWER, 16TH FLOOR GIV?ATAYIM L3 5320047
Business Address 4 ARIEL SHARON STREET HASHAHAR TOWER, 16TH FLOOR GIV?ATAYIM L3 5320047 972-3-6167055
Therapix Biosciences Ltd. (Subject) CIK: 0001611746 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-89951 | Film No.: 201003967
SIC: 2834 Pharmaceutical Preparations

Mailing Address 20 RAOUL WALENBERG ST TEL AVIV L3 6971916
Business Address 20 RAOUL WALENBERG ST TEL AVIV L3 6971916 972-3-7175777
L.I.A. Pure Capital Ltd (Filed by) CIK: 0001749628 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A